Dyadic says C1 biologics platform hits 15-day milestone in $4.5 million CEPI-FBS program
The company also said it received the full $3.1 million Gates Foundation grant and expects to deliver Bundibugyo Ebola antigen samples to Scripps Research by end-July 2026.